Current Cancer Drug Targets
Title: Author Index To Volume 1
Volume: 2 Issue: 1
Export Options
About this article
Cite this article as:
Author Index To Volume 1, Current Cancer Drug Targets 2002; 2 (1) . https://dx.doi.org/10.2174/1568009023333980
DOI https://dx.doi.org/10.2174/1568009023333980 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immune Response and Immunotherapy: Live Attenuated Listeria monocytogenes (Lm)-LLO Immunotherapy for the Treatment of Prostate Cancer
Current Cancer Therapy Reviews The Involvement of ERCC2/XPD and ERCC6/CSB Wild Type Alleles in Protection Against Aging and Cancer
Current Aging Science Bioengineering RNA Silencing Across the Life Kingdoms
Recent Patents on Biotechnology WNT4 Signaling in Female Gonadal Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Interaction of Tumor Suppressor p53 with DNA and Proteins
Current Pharmaceutical Biotechnology Editorial [ Hot topic: Pharmaceutical Design of Novel Anticancer Agents: A Lesson from Nature (Executive Editor: Q. Ping Dou)]
Current Pharmaceutical Design Lafora Progressive Myoclonus Epilepsy: Recent Insights into Cell Degeneration
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Selective Cyclooxygenase-2 (COX-2) Inhibitors Used for Preventing or Regressing Cancer
Recent Patents on Anti-Cancer Drug Discovery Ursolic Acid Attenuates HMGB1-induced LOX-1 Expression in Vascular Endothelial Cells in vitro and Inhibits Atherogenesis in Hypercholesterolemic Mice in vivo
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Application of Recombinant and Non-Recombinant Peptides in the Determination of Tumor Response to Cancer Therapy
Current Pharmaceutical Biotechnology Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Current Clinical Pharmacology Nanotechnology for Cancer Diagnostics and Therapy – An Update on Novel Molecular Players
Current Cancer Therapy Reviews β-Hydroxy-β-Methylbutyrate as a Countermeasure for Cancer Cachexia: A Cellular and Molecular Rationale
Anti-Cancer Agents in Medicinal Chemistry Postoperative Approach for Crohn's Disease: The Right Therapy to the Right Patient
Current Drug Targets “Forbidden” Disulfides: Their Role as Redox Switches
Current Protein & Peptide Science Effect of Selenium-Saturated Bovine Lactoferrin (Se-bLF) on Antioxidant Enzyme Activities in Human Gut Epithelial Cells Under Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells
Current Pharmaceutical Biotechnology Ionic Liquids for Topical Delivery in Cancer
Current Medicinal Chemistry Regulatory T Cells in Cancer Biology: A Possible New Target for Biochemical Therapies
Mini-Reviews in Medicinal Chemistry Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design
Current Pharmaceutical Design